Abdominal Ischemia-Reperfusion Induced Cardiac Dysfunction Can Be Prevented by MitoTEMPO.

Area of Science:

• Cardiovascular Research
• Mitochondrial Medicine
• Ischemia-Reperfusion Injury

Background:

• Cardiac dysfunction is a known complication of acute mesenteric ischemia (AMI) and abdominal aortic aneurysms (AAA).
• Ischemia-reperfusion (IR) injury leads to oxidative stress, causing damage to distant organs like the heart.
• Investigating protective agents against IR-induced cardiac damage is crucial.

Purpose of the Study:

• To evaluate the protective effects of MitoTEMPO, a novel mitochondria-targeted antioxidant, against abdominal ischemia-reperfusion (AIR) induced cardiac dysfunction.
• To assess the impact of MitoTEMPO on the contractile function and structural integrity of rat papillary muscle following AIR.

Main Methods:

• Adult Wistar-Albino rats were randomly assigned to three groups: sham-operated (SHAM), ischemia-reperfusion (IR) only, and IR with 28-day pretreatment of MitoTEMPO.
• The IR group underwent 1-hour aortic cross-clamping followed by 2 hours of reperfusion.
• Contractile function and structural properties of the papillary muscle were evaluated.

Main Results:

• Abdominal ischemia-reperfusion (AIR) significantly impaired the contractile function of the rat papillary muscle across various stimulation frequencies.
• MitoTEMPO pretreatment demonstrated a significant protective effect, preserving mechanical activities and structural integrity of the papillary muscle.
• AIR disrupted papillary muscle contractile function, affecting all measured mechanical parameters and post-potentiation responses, which was mitigated by MitoTEMPO.

Conclusions:

• Abdominal ischemia-reperfusion (AIR) appears to impair cardiac calcium homeostasis.
• MitoTEMPO exerts protective effects against AIR-induced cardiac damage, likely by targeting mitochondria and influencing energy metabolism.